Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 463

1.

Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.

Fahy JV, Boushey HA.

Clin Chest Med. 1995 Dec;16(4):715-33. Review.

PMID:
8565410
2.
3.

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ, Jaeschke R.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006922. doi: 10.1002/14651858.CD006922.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD006922.

PMID:
19588410
4.

Evidence for benefits of early intervention with non-steroidal drugs in asthma.

König P.

Pediatr Pulmonol Suppl. 1997 Sep;15:34-9. Review.

PMID:
9316100
5.

Evidence-based asthma management.

Kallstrom TJ.

Respir Care. 2004 Jul;49(7):783-92. Review.

6.

Managing symptoms and exacerbations in pediatric asthma.

Verberne AA.

Pediatr Pulmonol Suppl. 1997 Sep;15:46-50. Review.

PMID:
9316102
7.

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ, Jaeschke R.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006924. doi: 10.1002/14651858.CD006924.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD006924.

PMID:
19370661
8.

Long-term effects of asthma medications in children.

Tamesis GP, Covar RA.

Curr Opin Allergy Clin Immunol. 2008 Apr;8(2):163-7. doi: 10.1097/ACI.0b013e3282f50e9d. Review.

PMID:
18317027
9.

[Long acting beta-2 agonists in the treatment of asthma and their safety].

Türktaş H, Sekerel B, Karakay G, Yildiz F, Yorgancioğlu A.

Tuberk Toraks. 2011;59(4):409-15. Review. Turkish.

10.

Adverse effects of beta-agonists: are they clinically relevant?

Abramson MJ, Walters J, Walters EH.

Am J Respir Med. 2003;2(4):287-97. Review.

PMID:
14719995
11.
12.

Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.

Salpeter SR, Wall AJ, Buckley NS.

Am J Med. 2010 Apr;123(4):322-8.e2. doi: 10.1016/j.amjmed.2009.07.035. Epub 2010 Feb 20.

PMID:
20176343
13.

An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.

Salpeter SR.

Expert Opin Drug Saf. 2010 May;9(3):407-19. doi: 10.1517/14740330903535852. Review.

PMID:
20408768
14.

Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.

Ernst P, McIvor A, Ducharme FM, Boulet LP, FitzGerald M, Chapman KR, Bai T; Canadian Asthma Guideline Group.

Ann Intern Med. 2006 Nov 7;145(9):692-4. Review.

PMID:
17088583
15.

Comparative efficacy and safety of inhaled corticosteroids in asthma.

Jackson LD, Polygenis D, McIvor RA, Worthington I.

Can J Clin Pharmacol. 1999 Spring;6(1):26-37. Review.

PMID:
10465863
16.

Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.

Chung KF, Adcock IM.

Treat Respir Med. 2004;3(5):279-89. Review.

PMID:
15606218
17.

Safety of long-acting beta-agonists in asthma: a review.

Oppenheimer J, Nelson HS.

Curr Opin Pulm Med. 2008 Jan;14(1):64-9. Review.

PMID:
18043277
18.

Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?

Lipworth BJ, McDevitt DG.

Br J Clin Pharmacol. 1992 Feb;33(2):129-38. Review.

19.

The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease.

Bonay M, Bancal C, Crestani B.

Expert Opin Drug Saf. 2005 Mar;4(2):251-71. Review.

PMID:
15794718
20.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

Supplemental Content

Support Center